AsclepiX Therapeutics Funding & Investors
AsclepiX Therapeutics is revolutionizing the treatment of retinal diseases and cancer with a singular focus on the design, development, and delivery of novel peptides with the power to inhibit proven key disease pathways. Their peptide drug candidates tap into the body’s powerful mechanisms of maint... Read more
asclepix.comTotal Amount Raised: $50,000,000
AsclepiX Therapeutics Funding Rounds
Series A
$10,000,000
Series A Investors
Hibiscus Capital ManagementRapha Capital ManagementPerceptive AdvisorsSeries A
$35,000,000
Series A Investors
Barer & Son CapitalRapha Capital ManagementPerceptive AdvisorsConvertible Note
$5,000,000
Convertible Note Investors
Barer & Son CapitalPiedmont Capital PartnersRapha Capital ManagementSalem PartnersTEDCO
Funding info provided by Diffbot.